At AstronauTx our thesis is that changes in sleep architecture underpin disease and that sleep is a modifiable risk factor for chronic neurodegeneration. We have a unique portfolio of small-molecule therapeutics to restore dysregulated sleep physiology correcting sleep architecture to both improve symptoms and modify neurological disease progression.
| Website | https://astronautx.bio/ |
| Employees | 25 (15 on RocketReach) |
| Founded | 2019 |
| Industry | Biotechnology Research |
| Keywords | Neurodegenerative Diseases, Small Molecule Therapeutics, Drug Discovery, Biotechnology, Pharmaceutical, Therapeutics, Disease Treatment, Neurology, Clinical Trials, Drug Development, Pharmaceutical Research, Biopharma, Life Sciences, Molecular Medicine, Regenerative Medicine, Innovative Therapies, Hms, Health Technology, Biotech Research |
| Competitors | Novartis, Pfizer, Vertex Pharmaceuticals, Moderna Therapeutics, bluebird bio, CureVac, Rocket Pharmaceuticals, REGENXBIO Inc., Sangamo Therapeutics, Inc., Homology Medicines, Inc. +35 more (view full list) |
Looking for a particular AstronauTx employee's phone or email?
AstronauTx Questions
Hannah Pearce is the COO of AstronauTx.
15 people are employed at AstronauTx.
Top AstronauTx Employees
-
Hannah Pearce
Chief Operating Officer at AstronauTx
Cambridge, Cambridgeshire, United Kingdom33 -
Jane Rhodes
Chief Executive Officer at AstronauTx
Boston, MA, US35 -
Magnus Ivarsson
Chief Scientific Officer at AstronauTx
United Kingdom25+ -
Michelle Mellion
Chief Medical Officer at AstronauTx
Boston, MA, US35+ -
Borislav Dejanovic
Vice President, Head of Biology at AstronauTx
Cambridge, MA, US1 -
Keith Wafford
VP Head of Biology at AstronauTx
England, United Kingdom1 -
Elliott Bayle
Head of Medicinal Chemistry at AstronauTx
England, United Kingdom2 -
Alex Ceroni
Portfolio and Operations Director at AstronauTx
United Kingdom1 -
Adam Croucher
Director of Finance at AstronauTx
Cambridge, GB21
G2Crowd Trusted
300K+
Plugin Users
